Inhaled nitric oxide to treat intermediate risk pulmonary embolism: A multicenter randomized controlled trial
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Nitric Oxide
- Vol. 84, 60-68
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (UM1HL113203-01, UM1HL113203)
- Mallinckrodt Pharmaceuticals (UM1HL113203-01, UM1HL113203)
- Foundation for the National Institutes of Health (UM1HL113203-01, UM1HL113203)
- Edward Mallinckrodt, Jr. Foundation (UM1HL113203-01, UM1HL113203)
This publication has 27 references indexed in Scilit:
- No firm association between N-terminal pro-brain natriuretic peptide and percentage of pulmonary vascular obstruction in patients with acute pulmonary embolismThrombosis Research, 2011
- Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain CrisisJAMA, 2011
- Inhaled Nitrite Reverses Hemolysis-Induced Pulmonary Vasoconstriction in Newborn Lambs Without Blood ParticipationCirculation, 2011
- Intention-to-treat concept: A reviewPerspectives in Clinical Research, 2011
- Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of EchocardiographyJournal of the American Society of Echocardiography, 2010
- Reduction in plasma haptoglobin in humans with acute pulmonary embolism causing tricuspid regurgitationJournal of Thrombosis and Haemostasis, 2009
- Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic reviewEuropean Heart Journal, 2008
- Inhaled NO as a therapeutic agentCardiovascular Research, 2007
- Inhaled Nitric OxideCirculation, 2004
- Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusionThe Lancet, 1993